CARsgen® U.S. Clinical Holds Lifted by FDA

SHANGHAI,Nov. 1,2024-- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK),a company focused on innovative CAR T-cell therapies for the treatment of hematologic malignancies and solid tumors,

Home Previous 120 121 122 123 124 125 126 Next Tail

10 Items Per Page (Page 123 / 488) Total 4873 Items

©copyright 2009-2020 Nederlands Dagblad      Contact Us   SiteMap